{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:34:09Z","timestamp":1785789249656,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ataturk University","award":["TYL-2022-10746"],"award-info":[{"award-number":["TYL-2022-10746"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30026-0","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:44:34Z","timestamp":1765010674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cilazapril and benazepril mitigate neurodegeneration and \u03b1-synuclein accumulation in a cellular model of parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Oznur","family":"Altunlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-3313","authenticated-orcid":false,"given":"Ahmet","family":"Hacimuftuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmak Ferah","family":"Okkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Yesilyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Yoruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozkaraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"30026_CR1","doi-asserted-by":"publisher","unstructured":"Raza, C., Anjum, R. & Shakeel, N. U. A. Parkinson\u2019s disease: Mechanisms, translational models and management strategies. Life Sci. 226, 77\u201390. https:\/\/doi.org\/10.1016\/j.lfs.2019.03.057 (2019).","DOI":"10.1016\/j.lfs.2019.03.057"},{"key":"30026_CR2","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers. 3, 17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"30026_CR3","doi-asserted-by":"publisher","first-page":"110594","DOI":"10.1016\/j.biopha.2020.110594","volume":"131","author":"M Almezgagi","year":"2020","unstructured":"Almezgagi, M. et al. Diacerein: recent insight into Pharmacological activities and molecular pathways. Biomed. Pharmacother. 131, 110594. https:\/\/doi.org\/10.1016\/j.biopha.2020.110594 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"30026_CR4","doi-asserted-by":"publisher","unstructured":"LeWitt, P. A. Levodopa therapy for Parkinson\u2019s disease: Pharmacokinetics and pharmacodynamics. Mov Disord. 30 (1), 64\u201372 https:\/\/doi.org\/10.1002\/mds.26082 (2015).","DOI":"10.1002\/mds.26082"},{"issue":"12","key":"30026_CR5","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1007\/s11033-021-06779-y","volume":"48","author":"I Ferah Okkay","year":"2021","unstructured":"Ferah Okkay, I. et al. Neuroprotective effect of Bromelain in 6-hydroxydopamine induced in vitro model of parkinson\u2019s disease. Mol. Biol. Rep. 48 (12), 7711\u20137717. https:\/\/doi.org\/10.1007\/s11033-021-06779-y (2021).","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"30026_CR6","doi-asserted-by":"publisher","first-page":"pa008862","DOI":"10.1101\/cshperspect.a008862","volume":"1","author":"CG Goetz","year":"2011","unstructured":"Goetz, C. G. The history of parkinson\u2019s disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect. Med. 1 (1), pa008862. https:\/\/doi.org\/10.1101\/cshperspect.a008862 (2011).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"4","key":"30026_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1023\/A:1011972930917","volume":"8","author":"KJ Erdal","year":"2001","unstructured":"Erdal, K. J. Depression and anxiety in persons with parkinson\u2019s disease with and without On\u2013Off phenomena. J. Clin. Psychol. Med. Settings. 8 (4), 293\u2013299. https:\/\/doi.org\/10.1023\/A:1011972930917 (2001).","journal-title":"J. Clin. Psychol. Med. Settings"},{"issue":"3","key":"30026_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/1570159x17666181127125704","volume":"17","author":"I Carrera","year":"2019","unstructured":"Carrera, I. & Cacabelos, R. Current drugs and potential future neuroprotective compounds for parkinson\u2019s Disease. Curr. Neuropharmacol. 17 (3), 295\u2013306. https:\/\/doi.org\/10.2174\/1570159x17666181127125704 (2019).","journal-title":"Curr. Neuropharmacol."},{"key":"30026_CR9","doi-asserted-by":"publisher","unstructured":"Xicoy, H., Wieringa, B. & Martens, G. J. The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener. 12 (1), 10. https:\/\/doi.org\/10.1186\/s13024-017-0149-0  (2017).","DOI":"10.1186\/s13024-017-0149-0"},{"issue":"2","key":"30026_CR10","first-page":"14","volume":"3","author":"MA Y\u00f6r\u00fck","year":"2022","unstructured":"Y\u00f6r\u00fck, M. A. et al. Behavioral tests used in experimental animal models. Anatol. J. Biology. 3 (2), 14\u201322 (2022).","journal-title":"Anatol. J. Biology"},{"key":"30026_CR11","doi-asserted-by":"publisher","unstructured":"Kleinbloesem, C. H., van Brummelen, P., Francis, R. J. & Wiegand, U. W. Clinical pharmacology of cilazapril. Drugs 41 (Suppl 1), 3\u201310. https:\/\/doi.org\/10.2165\/00003495-199100411-00003 (1991).","DOI":"10.2165\/00003495-199100411-00003"},{"key":"30026_CR12","doi-asserted-by":"publisher","unstructured":"Sengul, G. et al. Neuroprotective effect of ACE inhibitors in glutamate - induced neurotoxicity: rat neuron culture study. Turk Neurosurg 21 (3), 367\u201371. https:\/\/doi.org\/10.5137\/1019-5149.Jtn.4313-11.0 (2011).","DOI":"10.5137\/1019-5149.Jtn.4313-11.0"},{"key":"30026_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15406\/ppij.2020.08.00276","volume":"8","author":"A Juszczak","year":"2020","unstructured":"Juszczak, A., Szczolko, W., Ramos, P., Pilawa, B. & Stanisz, B. Evaluation of antioxidant properties of angiotensin-converting enzyme inhibitors-interactions with free radicals model examined by EPR spectroscopy. Hosp. Pharmacol. - Int. Multidisciplinary J. 8, 25\u201332. https:\/\/doi.org\/10.15406\/ppij.2020.08.00276 (2020).","journal-title":"Hosp. Pharmacol. - Int. Multidisciplinary J."},{"issue":"4","key":"30026_CR14","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3892\/etm.2021.10516","volume":"22","author":"L Zhan","year":"2021","unstructured":"Zhan, L. et al. Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K\/Akt pathway. Exp. Ther. Med. 22 (4), 1082. https:\/\/doi.org\/10.3892\/etm.2021.10516 (2021).","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"30026_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11064-024-04312-8","volume":"50","author":"K Natarajan","year":"2024","unstructured":"Natarajan, K., Chandrasekaran, R., Sundararaj, R., Joseph, J. & Asaithambi, K. Neuroprotective assessment of nutraceutical (Betanin) in neuroblastoma cell line SHSY-5Y: an in-Vitro and in-Silico Approach. Neurochem Res. 50 (1), 54. https:\/\/doi.org\/10.1007\/s11064-024-04312-8 (2024).","journal-title":"Neurochem Res."},{"key":"30026_CR16","doi-asserted-by":"publisher","unstructured":"Ram, T. S. et al. In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease. J Ayurveda Integr Med 13 (1), 100413. https:\/\/doi.org\/10.1016\/j.jaim.2021.02.004 (2022).","DOI":"10.1016\/j.jaim.2021.02.004"},{"issue":"2","key":"30026_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clinbiochem.2003.10.014","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel, O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin. Biochem. 37 (2), 112\u2013119. https:\/\/doi.org\/10.1016\/j.clinbiochem.2003.10.014 (2004).","journal-title":"Clin. Biochem."},{"key":"30026_CR18","doi-asserted-by":"publisher","unstructured":"He, Q. et al. The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-\u03b1-Synuclein: Intranasal LPS Exposure on the A53T-\u03b1-Synuclein Transgenic Mouse Model of Parkinson\u2019s Disease. Mol Neurobiol 61 (9), 7046\u20137065. https:\/\/doi.org\/10.1007\/s12035-024-04020-y (2024).","DOI":"10.1007\/s12035-024-04020-y"},{"key":"30026_CR19","doi-asserted-by":"publisher","unstructured":"Bov\u00e9, J., Prou, D., Perier, C. & Przedborski, S. Toxin-induced models of Parkinson\u2019s disease. NeuroRx 2 (3), 484\u2013\u200994. https:\/\/doi.org\/10.1602\/neurorx.2.3.484 (2005).","DOI":"10.1602\/neurorx.2.3.484"},{"key":"30026_CR20","doi-asserted-by":"publisher","unstructured":"Terzioglu, M. & Galter, D. Parkinson\u2019s disease: genetic versus toxin-induced rodent models. Febs j. 275 (7), 1384\u20131391. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06302.x (2008).","DOI":"10.1111\/j.1742-4658.2008.06302.x"},{"issue":"3","key":"30026_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0925-4439(96)00020-8","volume":"1316","author":"W Linert","year":"1996","unstructured":"Linert, W. et al. Dopamine, 6-hydroxydopamine, iron, and dioxygen\u2013their mutual interactions and possible implication in the development of parkinson\u2019s disease. Biochim. Biophys. Acta. 1316 (3), 160\u2013168. https:\/\/doi.org\/10.1016\/0925-4439(96)00020-8 (1996).","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"30026_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1046\/j.1471-4159.2003.02299.x","volume":"89","author":"J Jord\u00e1n","year":"2004","unstructured":"Jord\u00e1n, J., Galindo, M. F., Tornero, D., Gonz\u00e1lez-Garc\u00eda, C. & Ce\u00f1a, V. Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells. J. Neurochem. 89 (1), 124\u2013133. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02299.x (2004).","journal-title":"J. Neurochem"},{"key":"30026_CR23","doi-asserted-by":"publisher","unstructured":"Watanabe, H., Ogura, T., Hosoya, M., Nishida, N. & Ota, Z. Diuretic effect of cilazapril and dopamine system in the spontaneously hypertensive rat. Acta Med Okayama. 49 (5), 247\u2009\u2013\u200952. https:\/\/doi.org\/10.18926\/amo\/30400 (1995).","DOI":"10.18926\/amo\/30400"},{"key":"30026_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","volume":"522","author":"S Latif","year":"2021","unstructured":"Latif, S. et al. Dopamine in parkinson\u2019s disease. Clin. Chim. Acta. 522, 114\u2013126. https:\/\/doi.org\/10.1016\/j.cca.2021.08.009 (2021).","journal-title":"Clin. Chim. Acta"},{"key":"30026_CR25","doi-asserted-by":"publisher","unstructured":"Bateman, B. T. et al. Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstet Gynecol. 129(1), 174\u2013184. https:\/\/doi.org\/10.1097\/aog.0000000000001775 (2017).","DOI":"10.1097\/aog.0000000000001775"},{"key":"30026_CR26","doi-asserted-by":"publisher","unstructured":"Kaur, P., Muthuraman, A. & Kaur, M. The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. ACS Chem Neurosci 6(4), 508\u2009\u2013\u200921. https:\/\/doi.org\/10.1021\/cn500363g (2015).","DOI":"10.1021\/cn500363g"},{"issue":"1","key":"30026_CR27","doi-asserted-by":"publisher","first-page":"28726","DOI":"10.1038\/s41598-024-78893-3","volume":"14","author":"P Antony","year":"2024","unstructured":"Antony, P. et al. Molecular insights into the Inhibition of angiotensin-converting enzyme 1 by hemopressin peptides. Sci. Rep. 14 (1), 28726. https:\/\/doi.org\/10.1038\/s41598-024-78893-3 (2024).","journal-title":"Sci. Rep."},{"key":"30026_CR28","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.jmgm.2022.108272","volume":"116","author":"M Halimi","year":"2022","unstructured":"Halimi, M. & Hajipasha, A. Pharmacophore modeling, Docking and molecular dynamic simulation studies in the discovery of potential human Renin inhibitors. J. Mol. Graph Model. 116, 108272. https:\/\/doi.org\/10.1016\/j.jmgm.2022.108272 (2022).","journal-title":"J. Mol. Graph Model."},{"issue":"11","key":"30026_CR29","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1039\/d1cp00172h","volume":"23","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Molecular dynamics investigation on the interaction of human angiotensin-converting enzyme with tetrapeptide inhibitors. Phys. Chem. Chem. Phys. 23 (11), 6685\u20136694. https:\/\/doi.org\/10.1039\/d1cp00172h (2021).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"30026_CR30","doi-asserted-by":"publisher","unstructured":"Martel, J. C., Gatti, S. & McArthur Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia. Front Pharmacol. 11, 1003. https:\/\/doi.org\/10.3389\/fphar.2020.01003 (2020).","DOI":"10.3389\/fphar.2020.01003"},{"key":"30026_CR31","doi-asserted-by":"publisher","unstructured":"Regulski, M. et al. Chemistry and pharmacology of Angiotensin-converting enzyme inhibitors. Curr Pharm Des. 21 (13), 1764-75. https:\/\/doi.org\/10.2174\/1381612820666141112160013 (2015).","DOI":"10.2174\/1381612820666141112160013"},{"key":"30026_CR32","doi-asserted-by":"publisher","unstructured":"Maiti, S., Banerjee, A. & Kanwar, M. In silico Nigellidine (N. sativa) bind to viral spike\/active-sites of ACE1\/2, AT1\/2 to prevent COVID-19 induced vaso-tumult\/vascular-damage\/comorbidity. Vascul Pharmacol 138, 106856. https:\/\/doi.org\/10.1016\/j.vph.2021.106856 (2021).","DOI":"10.1016\/j.vph.2021.106856"},{"key":"30026_CR33","doi-asserted-by":"publisher","unstructured":"Chang, K. H. & Chen, C. M. The Role of Oxidative Stress in Parkinson\u2019s Disease. Antioxidants (Basel) 9(7), https:\/\/doi.org\/10.3390\/antiox9070597 (2020).","DOI":"10.3390\/antiox9070597"},{"issue":"2","key":"30026_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.23876\/j.krcp.22.198","volume":"42","author":"TS Ha","year":"2023","unstructured":"Ha, T. S., Seong, S. B., Ha, D. S. & Kim, S. J. Upregulation of NADH\/NADPH oxidase 4 by angiotensin II induces podocyte apoptosis. Kidney Res. Clin. Pract. 42 (2), 202\u2013215. https:\/\/doi.org\/10.23876\/j.krcp.22.198 (2023).","journal-title":"Kidney Res. Clin. Pract."},{"key":"30026_CR35","doi-asserted-by":"publisher","unstructured":"Ghalayini, J. & Boulianne, G. L. Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer\u2019s disease. Front Neurosci 17 1166973. https:\/\/doi.org\/10.3389\/fnins.2023.1166973 (2023).","DOI":"10.3389\/fnins.2023.1166973"},{"issue":"2","key":"30026_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/jnc.15806","volume":"166","author":"TC Santiago","year":"2023","unstructured":"Santiago, T. C. et al. Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders. J. Neurochem. 166 (2), 138\u2013155. https:\/\/doi.org\/10.1111\/jnc.15806 (2023).","journal-title":"J. Neurochem"},{"issue":"3","key":"30026_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.sjbs.2020.01.026","volume":"27","author":"OA Abiodun","year":"2020","unstructured":"Abiodun, O. A. & Ola, M. S. Role of brain Renin angiotensin system in neurodegeneration: an update. Saudi J. Biol. Sci. 27 (3), 905\u2013912. https:\/\/doi.org\/10.1016\/j.sjbs.2020.01.026 (2020).","journal-title":"Saudi J. Biol. Sci."},{"key":"30026_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2016.02.011","volume":"617","author":"CC de Farias","year":"2016","unstructured":"de Farias, C. C. et al. Highly specific changes in antioxidant levels and lipid peroxidation in parkinson\u2019s disease and its progression: disease and staging biomarkers and new drug targets. Neurosci. Lett. 617, 66\u201371. https:\/\/doi.org\/10.1016\/j.neulet.2016.02.011 (2016).","journal-title":"Neurosci. Lett."},{"key":"30026_CR39","doi-asserted-by":"publisher","unstructured":"Tuon, T. et al. Behavior and oxidative stress parameters in rats subjected to the animal\u2019s models induced by chronic mild stress and 6-hydroxydopamine. Behav Brain Res. 406, 113226. https:\/\/doi.org\/10.1016\/j.bbr.2021.113226 (2021).","DOI":"10.1016\/j.bbr.2021.113226"},{"key":"30026_CR40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fphys.2014.00439","volume":"5","author":"R Vajapey","year":"2014","unstructured":"Vajapey, R., Rini, D., Walston, J. & Abadir, P. The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance. Front. Physiol. 5, 439. https:\/\/doi.org\/10.3389\/fphys.2014.00439 (2014).","journal-title":"Front. Physiol."},{"key":"30026_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-0716-3826-2_14","volume":"2798","author":"A Jim\u00e9nez","year":"2024","unstructured":"Jim\u00e9nez, A., Correa, S. & Sevilla, F. Identification of superoxide dismutase (SOD) isozymes in plant Tissues. Methods Mol. Biol. 2798, 205\u2013212. https:\/\/doi.org\/10.1007\/978-1-0716-3826-2_14 (2024).","journal-title":"Methods Mol. Biol."},{"key":"30026_CR42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cca.2018.07.021","volume":"485","author":"S Pandey","year":"2018","unstructured":"Pandey, S., Singh, B., Yadav, S. K. & Mahdi, A. A. Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and parkinson\u2019s disease (PD). Clin. Chim. Acta. 485, 258\u2013261. https:\/\/doi.org\/10.1016\/j.cca.2018.07.021 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"30026_CR43","doi-asserted-by":"publisher","unstructured":"Asanuma, M. et al. Region-Specific neuroprotective features of astrocytes against oxidative stress induced by 6-Hydroxydopamine. Int. J. Mol. Sci. 20 (3). https:\/\/doi.org\/10.3390\/ijms20030598 (2019).","DOI":"10.3390\/ijms20030598"},{"key":"30026_CR44","doi-asserted-by":"publisher","unstructured":"Waterfall, J. F. A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor. Br J Clin Pharmacol 27 (Suppl 2, no. Suppl 2), 139s-150s.https:\/\/doi.org\/10.1111\/j.1365-2125.1989.tb03475.x (1989).","DOI":"10.1111\/j.1365-2125.1989.tb03475.x"},{"key":"30026_CR45","doi-asserted-by":"publisher","unstructured":"Adamu, A., Li, S., Gao, F. & Xue, G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16, 1347987. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987 (2024).","DOI":"10.3389\/fnagi.2024.1347987"},{"key":"30026_CR46","doi-asserted-by":"publisher","unstructured":"Oosthuizen, D. & Sturrock, E. D. Exploring the Impact of ACE Inhibition in Immunity and Disease. J Renin Angiotensin Aldosterone Syst. 2022, 9028969. https:\/\/doi.org\/10.1155\/2022\/9028969 (2022).","DOI":"10.1155\/2022\/9028969"},{"issue":"1","key":"30026_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12974-022-02410-4","volume":"19","author":"AF Pike","year":"2022","unstructured":"Pike, A. F. et al. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for parkinson\u2019s disease. J. Neuroinflammation. 19 (1), 50. https:\/\/doi.org\/10.1186\/s12974-022-02410-4 (2022).","journal-title":"J. Neuroinflammation"},{"key":"30026_CR48","doi-asserted-by":"publisher","unstructured":"Mishra, J. et al. BBPT attenuated 6-OHDA-induced toxicity by modulating oxidative stress, apoptotic, and inflammatory proteins in primary neurons and rat models of Parkinson\u2019s disease. Neurotoxicology 105, 67\u201381. https:\/\/doi.org\/10.1016\/j.neuro.2024.08.008 (2024).","DOI":"10.1016\/j.neuro.2024.08.008"},{"key":"30026_CR49","doi-asserted-by":"publisher","unstructured":"Yang, M. H. et al. Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer\u2019s Disease Treatment. Molecules. 28, 16, https:\/\/doi.org\/10.3390\/molecules28165938 (2023).","DOI":"10.3390\/molecules28165938"},{"issue":"1","key":"30026_CR50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/abbs\/gmx124","volume":"50","author":"R Kashima","year":"2018","unstructured":"Kashima, R. & Hata, A. The role of TGF-\u03b2 superfamily signaling in neurological disorders. Acta Biochim. Biophys. Sin (Shanghai). 50 (1), 106\u2013120. https:\/\/doi.org\/10.1093\/abbs\/gmx124 (2018).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"30026_CR51","doi-asserted-by":"publisher","unstructured":"Labandeira-Garcia, J. L., Labandeira, C. M., Guerra, M. J. & Rodriguez-Perez, A. I. The role of the brain renin-angiotensin system in Parkinson\u00b4s disease. Transl Neurodegener 13 (1), 22. https:\/\/doi.org\/10.1186\/s40035-024-00410-3 (2024).","DOI":"10.1186\/s40035-024-00410-3"},{"key":"30026_CR52","doi-asserted-by":"publisher","unstructured":"Gouveia, F. et al. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer\u2019s disease: Past, present and future. Ageing Res Rev. 77, 101612. https:\/\/doi.org\/10.1016\/j.arr.2022.101612 (2022).","DOI":"10.1016\/j.arr.2022.101612"},{"key":"30026_CR53","doi-asserted-by":"publisher","unstructured":"M\u00e4rtin, A. et al. A Spatiomolecular Map of the Striatum. Cell Rep. 29 (13), 4320\u20134333.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.096 (2019).","DOI":"10.1016\/j.celrep.2019.11.096"},{"key":"30026_CR54","doi-asserted-by":"publisher","unstructured":"Liu, C. & Kaeser, P. S. Mechanisms and regulation of dopamine release. Curr Opin Neurobiol 57, 46\u201353. https:\/\/doi.org\/10.1016\/j.conb.2019.01.001 (2019).","DOI":"10.1016\/j.conb.2019.01.001"},{"key":"30026_CR55","doi-asserted-by":"crossref","unstructured":"Ganguly, U., Singh, S., Chakrabarti, S., Saini, A. K. & Saini, R. V. Chapter Ten - Immunotherapeutic interventions in Parkinson\u2019s disease: Focus on \u03b1-Synuclein, in Advances in Protein Chemistry and Structural Biology, vol. 129, R. Donev Ed.: Academic, 381\u2013433. (2022).","DOI":"10.1016\/bs.apcsb.2021.11.010"},{"key":"30026_CR56","doi-asserted-by":"publisher","first-page":"837890","DOI":"10.3389\/fphar.2022.837890","volume":"13","author":"Y Jo","year":"2022","unstructured":"Jo, Y., Kim, S., Ye, B. S., Lee, E. & Yu, Y. M. Protective effect of Renin-Angiotensin system inhibitors on parkinson\u2019s disease: A nationwide cohort Study. Front. Pharmacol. 13, 837890. https:\/\/doi.org\/10.3389\/fphar.2022.837890 (2022).","journal-title":"Front. Pharmacol."},{"issue":"8","key":"30026_CR57","doi-asserted-by":"publisher","first-page":"262","DOI":"10.52586\/4942","volume":"26","author":"B Ray","year":"2021","unstructured":"Ray, B. et al. Effects of Telmisartan, an AT1 receptor antagonist, on mitochondria-specific genes expression in a mouse MPTP model of Parkinsonism. Front. Biosci. (Landmark Ed). 26 (8), 262\u2013271. https:\/\/doi.org\/10.52586\/4942 (2021).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"30026_CR58","doi-asserted-by":"publisher","unstructured":"Park, S. Y., Kang, M. J. & Han, J. S. Neuronal NOS Induces Neuronal Differentiation Through a PKC\u03b1-Dependent GSK3\u03b2 Inactivation Pathway in Hippocampal Neural Progenitor Cells. Mol Neurobiol. 54 (7), 5646\u20135656. https:\/\/doi.org\/10.1007\/s12035-016-0110-1 (2017).","DOI":"10.1007\/s12035-016-0110-1"},{"key":"30026_CR59","doi-asserted-by":"publisher","unstructured":"Allboani, A., Kar, S. & Kavdia, M. Computational modeling of neuronal nitric oxide synthase biochemical pathway: A mechanistic analysis of tetrahydrobiopterin and oxidative stress. Free Radic Biol Med 222, 625\u2013637. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.07.011 (2024).","DOI":"10.1016\/j.freeradbiomed.2024.07.011"},{"key":"30026_CR60","doi-asserted-by":"publisher","unstructured":"Agrawal, S., Kumari, R., Sophronea, T., Kumari, N. & Luthra, P. M. Design and synthesis of benzo[d]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson\u2019s disease. Biomed Pharmacother. 156, 113838. https:\/\/doi.org\/10.1016\/j.biopha.2022.113838 (2022).","DOI":"10.1016\/j.biopha.2022.113838"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30026-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:57:11Z","timestamp":1767704231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30026-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30026"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30026-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"480"}}